Supervivencia Global en Segunda Línea de Liposarcomas: un objetivo alcanzado

77 / 86

SEOMGuidelines “Soft Tissue Sarcoma”
(2016)
1st Line 2nd Line
Doxorrubicin Trabectedin
Doxorrubicin + Ifosfamide Pazopanib
Ifosfamide Eribulin
Doxorrubicin + Olaratumab Gemcitabine + DTIC
Gem + Tax
High dose ifosfamide
López-Pousa A et al. SEOM Clinical Guideline of management of soft-tissue
sarcoma (2016). Clin Transl Oncol. 2016 Dec;18(12):1213-1220